Pathogenic roles of cardiac autoantibodies in dilated cardiomyopathy

Area of Science:

• Cardiology
• Immunology
• Autoimmune Diseases

Background:

• The role of autoimmunity in causing dilated cardiomyopathy (DCM) has been debated for decades.
• While autoantibodies against cardiac antigens are found in DCM patients, their causal role remained unproven.

Purpose of the Study:

• To address the long-standing controversy regarding autoimmunity as a cause of DCM.
• To discuss recent findings on autoantibodies inducing DCM and the potential of immunoglobulin-adsorption therapy.

Main Methods:

• Review of recent studies investigating autoantibodies in DCM.
• Discussion of experimental induction of DCM in mice using autoantibodies against cardiac troponin I (cTnI).
• Exploration of clinical trials involving immunoglobulin-adsorption therapy for DCM.

Main Results:

• Recent research demonstrates that autoantibodies against cTnI can experimentally induce DCM in normal mice.
• This finding provides strong evidence that autoimmunity can indeed cause DCM, resolving prior disputes.
• Early results from immunoglobulin-adsorption therapy trials for DCM in Germany appear promising.

Conclusions:

• Autoimmunity, specifically autoantibodies against cTnI, is a confirmed cause of dilated cardiomyopathy.
• Immunoglobulin-adsorption therapy shows potential as a treatment for this life-threatening cardiac condition.